Regulating DTC Is All the Rage, Suddenly. But It Turns Out that Americans Do Want to Hear from Brands
Shares:
In some ways, I’ve given up on my dream that stories about beginning-of-the-year price changes for prescription drugs will be thoughtful. Yes, it would be nice if the stories were
The “smoothing” provision is the most important part of the IRA that no one has heard of (I mean, you all have heard of it, but I don’t consider any
Scheduling Note: Cost Curve is off tomorrow. Back on Friday The two most important stories today are a pair out of Reuters on the obstacles that payers are erecting around